Home Clinical relevance of non-cardiac determinants of natriuretic peptide levels
Article
Licensed
Unlicensed Requires Authentication

Clinical relevance of non-cardiac determinants of natriuretic peptide levels

  • Claudio Passino , Roberta Poletti , Marianna Fontana , Giuseppe Vergaro , Concetta Prontera , Alessandra Gabutti , Alberto Giannoni , Michele Emdin and Aldo Clerico
Published/Copyright: November 1, 2008

Abstract

There is evidence that natriuretic peptide (namely atrial and/or B-type natriuretic peptides) plasma concentration may be elevated in many clinical conditions besides cardiovascular diseases, the most frequent being lung diseases, renal and liver failure, acute cerebrovascular events, acute and chronic inflammatory diseases and certain metabolic and endocrine disorders. In general, increased circulating levels of natriuretic peptides (compared to the normal range of a healthy population) may be considered expression of activation of the neuro-endocrine system, which can be the cause or consequence of cardiac stressor events. Furthermore, some variables, such as gender and obesity, may affect natriuretic peptide secretion and plasma concentration by completely extra-cardiac mechanisms. Increased expression of the natriuretic peptide system, counteracting neuro-hormonal and immunological activation, may occur in many clinical conditions, as witnessed by the considerable number of diseases in which the natriuretic peptide system has been found to be altered. Several studies have demonstrated that higher circulating levels of natriuretic peptides represent a strong independent risk factor for major cardiovascular complications and/or death, even in extra-cardiac diseases. Because several of these diseases may be present in patients with left ventricular dysfunction, the possible influence on diagnostic and prognostic accuracy of natriuretic peptides in heart failure will be discussed.

Clin Chem Lab Med 2008;46:1515–23.


Corresponding author: Claudio Passino, MD, Department of Cardiovascular Medicine, G. Monasterio Foundation, Via Moruzzi 1, 56124 Pisa, Italy Phone: +39-050-3152191, Fax: +39-050-3152109,

Received: 2008-6-4
Accepted: 2008-9-15
Published Online: 2008-11-01
Published in Print: 2008-11-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Biochemical markers in clinical cardiology: perspectives from present to future. 1st IFCC-Ortho Clinical Diagnostics Conference on Clinical Diagnosis and the Clinical Laboratory
  3. Highlight: Cardiovascular Biomarkers
  4. Reviews
  5. The clinical impact of the universal diagnosis of myocardial infarction
  6. Troponin revisited 2008: assay performance
  7. Standardization of troponin I measurements: an update
  8. Biochemistry of B-type natriuretic peptide – where are we now?
  9. Clinical relevance of non-cardiac determinants of natriuretic peptide levels
  10. What is the value of B-type natriuretic peptide testing for diagnosis, prognosis or monitoring of critically ill adult patients in intensive care?
  11. Natriuretic peptide testing in primary care patients
  12. Natriuretic peptide testing in emergency settings
  13. Minireviews
  14. Oxidative stress, free radicals and bone remodeling
  15. Plasma homocysteine and vascular disease in elderly patients with mental illness
  16. Opinion Papers
  17. Fate of abstracts presented at the 2002 IFCC meeting
  18. Transition from congress abstract to full paper: the case of a national Argentinean congress in clinical laboratory
  19. Genetics and Molecular Diagnostics
  20. Association of endothelin-1 gene polymorphisms with variant angina in Korean patients
  21. Single nucleotide polymorphisms in ABCG5 and ABCG8 genes in Chilean subjects with polygenic hypercholesterolemia and controls
  22. Paternal exclusion: allele sharing in microsatellite testing
  23. General Clinical Chemistry
  24. Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes
  25. Plasma bilirubin correlations in non-obstructive cholestasis after partial hepatectomy
  26. Aggregation of lipoprotein and inflammatory parameters in families with a history of premature myocardial infarction: the Tallinn Myocardial Infarction Study
  27. Significant elevation of a Th2 cytokine, interleukin-10, in pelvic inflammatory disease
  28. Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study
  29. The effect of the mode of delivery on maternal-neonatal interleukin-6, biogenic amine and their precursor amino acid concentrations
  30. A rapid liquid chromatography-tandem mass spectrometry analysis of whole blood sirolimus using turbulent flow technology for online extraction
  31. Validation and Outcome Studies
  32. Benefits of the iQ200 automated urine microscopy analyser in routine urinalysis
  33. Electrochemical detection of blood alcohol concentration using a disposable biosensor based on screen-printed electrode modified with Nafion and gold nanoparticles
  34. About the z-multiplier in total error calculations
  35. Letters to the Editor
  36. A hypothyroid patient with increased free thyroid hormones
  37. Evaluation of blood collection tubes specific for homocysteine measurement
  38. Influence of assay-dependent variability of serum insulin levels on insulin sensitivity indices
  39. Frequency and type of preanalytical errors in a laboratory medicine department in India
  40. Sample dilution causes a positive bias on C-reactive protein using VITROS reagents, diluents and instruments – clinical implications?
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.293/html
Scroll to top button